In preclinical studies, MW150 demonstrated the ability to inhibit hippocampal-dependent associative and spatial memory deficits in AD-related APP/PS1 knock-in mouse models, effectively modulating neuroinflammatory responses by reducing inflammatory cytokines [257,259]. The gene discussed is APP; the disease is Alzheimer disease.